Overview

Cholecalciferol in Chronic Inflammatory Bowel Diseases

Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
In our research project, we want to find out whether the additional intake of vitamin D further reduces the inflammatory events in the intestines of IBD patients. There are three groups of subjects: the 1st group takes a capsule of 24,000 IU per week, the 2nd group takes 24,000 IU per month, the 3rd group is the control group. The intake extends over 6 months during the autumn and winter period.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital, Basel, Switzerland
Treatments:
Vitamin D